Daniel Newman Mendelson - 05 Nov 2026 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Nov 2026, 16:39:27 UTC
Prior SEC filing
07 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Mendelson
Filing notes and source

Key filing fact

Daniel Newman Mendelson filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 09 Nov 2026.

Key facts

  • This page summarizes Daniel Newman Mendelson's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 09 Nov 2026, 16:39.

Change

  • Previous filing in this sequence was filed on 07 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001327897 Primary reporting owner

Mendelson Daniel Newman

Relationship
Director
Address
C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK
Signature
/s/ Daniel Mendelson
Signature date
09 Nov 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Award

Transaction value
Shares
+20,291
Change %
Price
$4.76*
Shares after
20,291
Date
05 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,291
Exercise price
$4.76
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .